- Modest glucose-lowering effect of sacubitril/valsartan via reduced HbA1c and insulin initiation was similar in heart failure (HF) patients with diabetes across left ventricular ejection fraction (LVEF) spectrum.
- Low hypoglycemia risk.
Why this matters
- Diabetes is common in patients with HF with preserved ejection fraction.
- Diabetes and elevated HbA1c are...